Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
RESEARCH TOOLSreports
Holding APLS?
Track your performance easily
Apellis Pharmaceuticals (APLS) Ownership Overview
3.21% Insiders
27.77% Mutual Funds
0.11% Other Institutional Investors
14.22% ETFs
54.70% Public Companies and Individual Investors
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 42.09% of the company’s stock is owned by Institutional Investors, 3.21% is owned by Insiders, and 54.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 14, 2025 | xxxxxxxxxxxxx | $77060 | |
| Jan 14, 2025 | xxxxxxxxxxxxx | $142496 | |
| Jan 14, 2025 | xxxxxxxxxxxxx | $75538 | |
| Jan 14, 2025 | xxxxxxxxxxxxx | $62279 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $486617 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $5438185 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,088,600 | Institution | 8.11% | 292,872,058 | |
| 9,266,091 | Institution | 7.45% | 268,994,622 | |
| 8,894,854 | Institution | 7.15% | 258,217,612 | |
| 2,699,392 | Institution | 2.17% | 78,363,350 | |
| 2,552,866 | Institution | 2.05% | 74,109,700 | |
| 1,969,268 | Institution | 1.58% | 57,167,850 | |
| 1,846,837 | Insider | 1.48% | 53,613,678 | |
| 1,405,784 | Institution | 1.13% | 40,809,910 | |
| 1,309,394 | Institution | 1.05% | 38,011,708 | |
| 1,200,000 | Institution | 0.96% | 34,836,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,088,600 | Institution | 8.11% | 292,872,058 | |
| 8,894,854 | Institution | 7.15% | 258,217,612 | |
| 1,969,268 | Institution | 1.58% | 57,167,850 | |
| 1,405,784 | Institution | 1.13% | 40,809,910 | |
| 1,200,000 | Institution | 0.96% | 34,836,000 | |
| 1,189,654 | Institution | 0.96% | 34,535,656 | |
| 986,546 | Institution | 0.79% | 28,639,430 | |
| 956,079 | Institution | 0.77% | 27,754,973 | |
| 695,805 | Institution | 0.56% | 20,199,219 | |
| 493,300 | Institution | 0.40% | 14,320,499 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,258,050 | Institution | 2.62% | 110,545,637 | |
| 2,693,133 | Institution | 2.17% | 74,572,853 | |
| 2,609,953 | Institution | 2.10% | 88,555,705 | |
| 1,574,637 | Institution | 1.27% | 53,427,433 | |
| 1,435,077 | Institution | 1.15% | 48,692,163 | |
| 647,412 | Institution | 0.52% | 18,794,370 | |
| 607,432 | Institution | 0.49% | 17,633,751 | |
| 518,508 | Institution | 0.42% | 14,357,487 | |
| 371,270 | Institution | 0.30% | 10,777,968 | |
| 341,220 | Institution | 0.27% | 9,905,617 |
FAQ
Who Owns Apellis Pharmaceuticals Inc (APLS)?
According to the latest TipRanks data, approximately 0.11% of the company's stock is held by institutional investors, 3.21% is held by insiders, and 54.70% is held by retail investors.
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.11% of Apellis Pharmaceuticals Inc (APLS) stock is held by institutional investors.
What percentage of Apellis Pharmaceuticals Inc (APLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.70% of Apellis Pharmaceuticals Inc (APLS) stock is held by retail investors.
Who owns the most shares of Apellis Pharmaceuticals Inc (APLS)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Apellis Pharmaceuticals Inc (APLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.